These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6788942)

  • 21. [Parasitic infections in pregnancy and congenital protozoan infections. Part I.: Protozoan infections].
    Bialek R; Knobloch J
    Z Geburtshilfe Neonatol; 1999; 203(2):55-62. PubMed ID: 10420511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
    Orosco D; Mendoza AR; Meléndez CM
    Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drugs used against protozoan infections in man].
    Takada S
    Nihon Rinsho; 1990 Oct; 48(10):2228-33. PubMed ID: 2280469
    [No Abstract]   [Full Text] [Related]  

  • 24. Tinidazole, a new antiprotozoal agent: Effect on Trichomonas and other protozoa.
    Howes HL; Lynch JE; Kivlin JL
    Antimicrob Agents Chemother (Bethesda); 1969; 9():261-6. PubMed ID: 5396498
    [No Abstract]   [Full Text] [Related]  

  • 25. The chemotherapy of protozoal infections of veterinary importance.
    Joyner LP
    J Protozool; 1981 Feb; 28(1):17-9. PubMed ID: 7019418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parasitology. Drugs to combat tropical protozoan parasites.
    Gelb MH; Hol WG
    Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
    [No Abstract]   [Full Text] [Related]  

  • 27. Intestinal parasitic infections.
    Botero D
    Antibiot Chemother (1971); 1981; 30():1-19. PubMed ID: 7259130
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of intestinal parasitic infections: a review of nitazoxanide.
    Gilles HM; Hoffman PS
    Trends Parasitol; 2002 Mar; 18(3):95-7. PubMed ID: 11854075
    [No Abstract]   [Full Text] [Related]  

  • 29. Human antiprotozoal therapy: past, present, and future.
    Khaw M; Panosian CB
    Clin Microbiol Rev; 1995 Jul; 8(3):427-39. PubMed ID: 7553575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The combined action of pyrimidines and sulfonamides or sulfones in the chemotherapy of malaria and other protozoal infections.
    Richards WH
    Adv Pharmacol Chemother; 1970; 8():121-47. PubMed ID: 5002795
    [No Abstract]   [Full Text] [Related]  

  • 31. Common and uncommon parasitic infections in the United States.
    Tan JS
    Med Clin North Am; 1978 Sep; 62(5):1059-81. PubMed ID: 104098
    [No Abstract]   [Full Text] [Related]  

  • 32. The apicoplast as a potential therapeutic target in and other apicomplexan parasites.
    Soldati D
    Parasitol Today; 1999 Jan; 15(1):5-7. PubMed ID: 10234168
    [No Abstract]   [Full Text] [Related]  

  • 33. Potent antiprotozoal activity of a novel semi-synthetic berberine derivative.
    Bahar M; Deng Y; Zhu X; He S; Pandharkar T; Drew ME; Navarro-Vázquez A; Anklin C; Gil RR; Doskotch RW; Werbovetz KA; Kinghorn AD
    Bioorg Med Chem Lett; 2011 May; 21(9):2606-10. PubMed ID: 21474310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological evaluation of glycosyl-isoindigo derivatives against the pathogenic agents of tropical diseases (malaria, Chagas disease, leishmaniasis and human African trypanosomiasis).
    Bouchikhi F; Anizon F; Brun R; Moreau P
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6319-21. PubMed ID: 21937228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of intestinal parasitic diseases].
    Levi GC
    AMB Rev Assoc Med Bras; 1982; 28 Suppl 1():20-4. PubMed ID: 6984969
    [No Abstract]   [Full Text] [Related]  

  • 36. Infectious diseases. Overcoming neglect of kinetoplastid diseases.
    Bilbe G
    Science; 2015 May; 348(6238):974-6. PubMed ID: 26023124
    [No Abstract]   [Full Text] [Related]  

  • 37. [Serological problems in the diagnosis of protozoal diseases (author's transl)].
    Mohr W
    MMW Munch Med Wochenschr; 1974 Aug; 116(34):1459-66. PubMed ID: 4215001
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis.
    Jain V; Yogavel M; Kikuchi H; Oshima Y; Hariguchi N; Matsumoto M; Goel P; Touquet B; Jumani RS; Tacchini-Cottier F; Harlos K; Huston CD; Hakimi MA; Sharma A
    Structure; 2017 Oct; 25(10):1495-1505.e6. PubMed ID: 28867614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease.
    Future Med Chem; 2013 Oct; 5(15):1709-18. PubMed ID: 24144408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Overview of Drug Resistance in Protozoal Diseases.
    Capela R; Moreira R; Lopes F
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31731801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.